摘要 Objective: Taiwan has an increasing aging population like other developed areas. The aging population will lead to an increased prevalence of dementia. Methods: This article will reflect the status of dementia in Taiwan, including updated epidemiology, diagnosis, subtypes, and optimal treatment of dementia. Results: The article also describes and interprets the Taiwan Dementia Policy to establish a clear, large view of the current state of management of dementia in Taiwan and future policy implementation. Conclusion: A comprehensive policy to dementia, from the basic researches to clinical care and treatment, is necessary to the increased aged population in Taiwan.
Abstract: Objective: Taiwan has an increasing aging population like other developed areas. The aging population will lead to an increased prevalence of dementia. Methods: This article will reflect the status of dementia in Taiwan, including updated epidemiology, diagnosis, subtypes, and optimal treatment of dementia. Results: The article also describes and interprets the Taiwan Dementia Policy to establish a clear, large view of the current state of management of dementia in Taiwan and future policy implementation. Conclusion: A comprehensive policy to dementia, from the basic researches to clinical care and treatment, is necessary to the increased aged population in Taiwan.
[1] Fuh JL, Wang SJ. Dementia in Taiwan: Past, present, and future. Acta Neurol Taiwan 2008, 17(3): 153-161.
[2] Sun Y, Lee HJ, Yang SC, Chen TF, Lin KN, Lin CC, Wang PN, Tang LY, Chiu MJ. A “nationwide” survey of mild cognitive impairment and dementia, including very mild dementia. PLoS One 2014, 9(6): e100303.
[3] Chen CH, Wang LC, Ma TC, Yang YH. A walk-in screening of dementia in the general population in Taiwan. Sci World J 2014, 2014: Article ID 243738.
[4] Wu YT, Lee HY, Norton S, Chen CF, Chen HX, He CL, Fleming J, Matthews FE, Brayne C. Prevalence studies of dementia in Mainland China, Hong Kong and Taiwan: A systematic review and meta-analysis. PLoS One 2013, 8(6): e66252.
[5] Wang WF, Chiu PY, Lin YT, Hu CJ, Fuh JL, Yang YH. Registration of Alzheimer's disease in Taiwan: Patient and informant. Am J Alzheimers Dis Other Demen 2014, 29(1): 18-22.
[6] Yang YH, Wang H, Lam L, Chan WC, Yu X, Li T, Wang WF, Chiu PY, Lin YT, Hu CJ, Fuh JL, Morris JC. Characteristics of Alzheimer's disease among patients in Taiwan, Hong Kong, and Beijing. J Alzheimers Dis 2014, 42(1): 193-200.
[7] Yang YH, Meguro K, Kim SY, Shim YS, Yu X, Chen CL, Wang H, Lam L, Senanarong V, Dominguez J, Lu PY, Lin YT, Hu CJ, Chiu PY, Fuh JL, Wang WF, Yu BC, Li T, Wang MW, Situmeang RF, Jang JW, Zhang J, Chan WC, Zhou YY, Lou HL, Zhang L, Ye M, Chen X. Impact of Alzheimer's disease in nine Asian Countries. Gerontology, in press, DOI 10.1159/000443525.
[8] Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3): 189-198.
[9] Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984, 141(11): 1356-1364.
[10] Lin KN, Wang PN, Liu CY, Chen WT, Lee YC, Liu HC. Cutoff scores of the cognitive abilities screening instrument, Chinese version in screening of dementia. Dement Geriatr Cogn Disord 2002, 14(4): 176-182.
[11] Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994, 44(12): 2308-2314.
[12] Morris JC. The clinical dementia rating (CDR): Current version and scoring rules. Neurology 1993, 43(11): 2412-2414.
[13] Yang YH, Galvin JE, Morris JC, Lai CL, Chou MC, Liu CK. Application of AD8 questionnaire to screen very mild dementia in “Taiwanese”. Am J Alzheimers Dis Other Demen 2011, 26(2): 134-138.
[14] Chou MC, Chen CH, Liu CK, Chen SH, Wu SJ, Yang YH. Concentrations of rivastigmine and NAP 226-90 and the cognitive response in “Taiwanese” Alzheimer's disease patients. J Alzheimers Dis 2012, 31(4): 857-864.
[15] Yang YH, Wu SL, Chou MC, Lai CL, Chen SH, Liu CK. Plasma concentration of donepezil to the therapeutic response of Alzheimer's disease in “Taiwanese”. J Alzheimers Dis 2011, 23(3): 391-397.
[16] Yang YH, Chen CH, Chou MC, Li CH, Liu CK, Chen SH. Concentration of donepezil to the cognitive response in Alzheimer disease. J Clin Psychopharmacol 2013, 33(3): 351-355.
[17] Chang YP, Yang CH, Chou MC, Chen CH, Yang YH. Clinical compliance of donepezil in treating Alzheimer's disease in Taiwan. Am J Alzheimers Dis Other Demen 2015, 30(4): 346-351.
[18] Guideline subcommittee of the Taiwan dementia society. Guidelines for the medical treatment of patients with Alzheimer's disease. Acta Neurol Taiwan 2011, 20(2): 85-100.
[19] “National Health Insurance Administration”. “National Health Insurance Administration” payment guidelines for drugs acting on the nervous system [Online]. “National Health Insurance Administration”, 2016. http://www.nhi.gov.tw/ webdata/webdata.aspx?menu=21&menu_id=713&webdata_ id=2919.
[20] Sun Y, Lai MS, Lu CJ, Chen RC. How long can patients with mild or moderate Alzheimer's dementia maintain both the cognition and the therapy of cholinesterase inhibitors: A “national” population-based study. Eur J Neurol 2008, 15(3): 278-283.
[21] Lin SK, Tsai YT, Lai JN, Wu CT. Demographic and medication characteristics of traditional Chinese medicine users among dementia patients in Taiwan: A “nationwide” database study. J Ethnopharmacol 2015, 161: 108-115.
[22] “National Center for Complementary and Integrative Health”. Dietary supplements and cognitive function, Dementia, and Alzheimer's disease [Online]. “National Center for Complementary and Integrative Health”, https://nccih.nih.gov/ health/providers/digest/alzheimers.htm.
[23] Taiwan Alzheimer Disease association website. http:// www.tada2002.org.tw/tada_know_02.html.
[24] Li CH, Liu CK, Yang YH, Chou MC, Chen CH, Lai CL. Adjunct effect of music therapy on cognition in Alzheimer's disease in Taiwan: A pilot study. Neuropsychiatr Dis Treat 2015, 11: 291-296.
[25] “Taiwan Ministry of Health and Welfare”. Taiwan dementia policy: A framework for prevention and Care [Online]. “Taiwan Ministry of Health and Welfare”, 2014. http: //www.mohw.gov.tw/EN/Ministry/DM2_P.aspx?f_list_no= 475&fod_list_no=5160&doc_no=46373&rn=584790997.
2016, Vol. 2 
